COVID-19 vaccines: factors contributing to a ‘fast-track’ development
Domenica Sardone, Regulatory Program Associate Director, Roche Ltd. The COVID-19 pandemic has demanded a new global approach to vaccine development. There has been unprecedented international attention, cooperation and especially use of resources, enabling pharmaceutical companies and governmental bodies to act at speed in the interest of public health. During this challenging times and considering the … Read more